The Bekris lab is focused on Alzheimer's Disease Biomarker Discovery and uses clinical and experimental approaches to demonstrate the feasibility of genetic and epigenetic factors underlying soluble protein expression as either potential early-stage drug targets or early biomarkers of disease risk, progression, and therapeutic outcomes.
Research Interests
Proteomics